These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28986133)

  • 1. Glycated albumin predicts the development of early diabetic nephropathy in patients with type 2 diabetes.
    Jun JE; Hur KY; Lee YB; Lee SE; Jin SM; Lee MK; Kim JH
    Diabetes Metab; 2018 Mar; 44(2):178-180. PubMed ID: 28986133
    [No Abstract]   [Full Text] [Related]  

  • 2. Variability in glycated albumin levels predicts the progression of diabetic nephropathy.
    Park SB; Kim SS; Kim IJ; Nam YJ; Ahn KH; Kim JH; Jeon YK; Kim BH; Song SH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2017 Jun; 31(6):1041-1046. PubMed ID: 28396158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insights on glycated albumin].
    Hay-Lombardie A; Kamel S; Bigot-Corbel E
    Ann Biol Clin (Paris); 2019 Aug; 77(4):407-414. PubMed ID: 31418702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries.
    Schalkwijk CG; Ligtvoet N; Twaalfhoven H; Jager A; Blaauwgeers HG; Schlingemann RO; Tarnow L; Parving HH; Stehouwer CD; van Hinsbergh VW
    Diabetes; 1999 Dec; 48(12):2446-53. PubMed ID: 10580435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycated albumin and continuous glucose monitoring to replace glycated haemoglobin in patients with diabetes treated with haemodialysis.
    Meyer L; Chantrel F; Imhoff O; Sissoko A; Serb L; Dorey F; Fleury D; Smagala A; Kepenekian L; Krummel T; Le Floch JP; Kessler L
    Diabet Med; 2013 Nov; 30(11):1388-9. PubMed ID: 23909880
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis.
    Yajima T; Yajima K; Hayashi M; Yasuda K; Takahashi H; Yamakita N
    J Diabetes Complications; 2016 Jul; 30(5):786-9. PubMed ID: 27009773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordance in the levels of hemoglobin A1C and glycated albumin: Calculation of the glycation gap based on glycated albumin level.
    Kim MK; Yun KJ; Kwon HS; Baek KH; Song KH
    J Diabetes Complications; 2016 Apr; 30(3):477-81. PubMed ID: 26803475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus.
    Wang N; Xu Z; Han P; Li T
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27537245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal handling of glycated albumin in non-insulin-dependent diabetes mellitus with nephropathy.
    Cha T; Tahara Y; Yamato E; Yoneda H; Ikegami H; Noma Y; Shima K; Ogihara T
    Diabetes Res Clin Pract; 1991 Jul; 12(3):149-56. PubMed ID: 1889345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated albumin and the risk of chronic kidney disease in subjects with Type 2 Diabetes: A study in North Indian Population.
    Raghav A; Ahmad J; Noor S; Alam K; Mishra BK
    Diabetes Metab Syndr; 2018 May; 12(3):381-385. PubMed ID: 29396252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycated albumin in serum and dialysate of patients on continuous ambulatory peritoneal dialysis.
    Lamb E; Cattell WR; Dawnay A
    Clin Sci (Lond); 1993 Jun; 84(6):619-26. PubMed ID: 8334808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control in patients with diabetes and nephropathy.
    Freedman BI; Tuttle AB
    JAAPA; 2012 Nov; 25(11):30. PubMed ID: 23620921
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
    Copur S; Siriopol D; Afsar B; Comert MC; Uzunkopru G; Sag AA; Ortiz A; Covic A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
    Acta Diabetol; 2021 Jan; 58(1):81-91. PubMed ID: 32862262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of serum glycated albumin and high sensitivity C - reactive protein in the insight of cardiovascular complications in diabetic chronic kidney disease patients.
    Vijayaraghavan B; Padmanabhan G; Ramanathan K
    Afr Health Sci; 2020 Mar; 20(1):308-313. PubMed ID: 33402919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
    Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
    J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycation of serum albumin and its role in renal protein excretion and the development of diabetic nephropathy.
    Bundschuh I; Jäckle-Meyer I; Lüneberg E; Bentzel C; Petzoldt R; Stolte H
    Eur J Clin Chem Clin Biochem; 1992 Oct; 30(10):651-6. PubMed ID: 1493158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the accuracy of glycemic markers and the chronic kidney disease stage in patients with type 2 diabetes mellitus.
    Harada K; Sumida K; Yamaguchi Y; Akai Y
    Clin Nephrol; 2014 Aug; 82(2):107-14. PubMed ID: 24985951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
    Hasslacher C; Kulozik F
    J Diabetes; 2016 Sep; 8(5):712-9. PubMed ID: 26615054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes.
    Pu LJ; Lu L; Xu XW; Zhang RY; Zhang Q; Zhang JS; Hu J; Yang ZK; Ding FH; Chen QJ; Lou S; Shen J; Fang DH; Shen WF
    Cardiovasc Diabetol; 2006 Dec; 5():27. PubMed ID: 17178005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.